Answers are grounded in this paper and cite their sources.
Retrospective case-control study quantifies tear-film disruption in noninfectious acute anterior uveitis, suggesting early protection may be needed.
The study aimed to quantify the acute tear-film disruption in treatment-naive, 1st-onset noninfectious acute anterior uveitis (AAU) and identify independent and modifiable determinants. Retrospective case-control study enrolling 180 AAU eyes and 90 age-/sex-matched healthy controls. Same-day noninvasive tear breakup time (NIBUT), tear meniscus height, Schirmer-I and Ocular Surface Disease Index were extracted. Multivariable linear regression with bootstrap correction determined predictors of shorter NIBUT. Mean NIBUT was 4.7 seconds lower in AAU than controls (5.7 ± 1.5 seconds vs 10.4 ± 1.5 seconds; P < .001); 66% of AAU eyes versus 2% of controls had NIBUT ≤ 5 seconds. Tear meniscus height (−81 μm), Schirmer-I (−5.3 mm) and Ocular Surface Disease Index (+24 points) all worsened ( P < .001). Independent reductions in NIBUT: anterior-chamber cells ≥ 2+ (−1.79 seconds), flare ≥ 3+ (−1.23 seconds), concomitant meibomian gland dysfunction (−0.96 seconds) and daily screen time > 8 hours (−0.59 seconds); adjusted R 2 = 0.38, optimism-corrected R 2 = 0.35. In this proof-of-concept study, 1st-onset AAU was associated with measurable tear-film destabilization driven by intraocular inflammatory load. While these findings suggest a potential role for early ocular-surface protection, effect sizes represent upper-bound estimates requiring confirmation in unscreened populations before routine clinical application.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: